Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Children's Oncology Group
With
OBJECTIVES: Primary * Determine the pharmacokinetics of daunorubicin hydrochloride in pediatric patients with malignancy. Secondary * Evaluate the relationship between body composition (percent body fat) and the pharmacokinetics of daunorubicin hydrochloride in these patients. * Correlate the pharmacokinetics of daunorubicin hydrochloride with gender, age, or ethnic background in these patients. * Explore, in a preliminary fashion, possible relationships between pharmacokinetic results and toxicity. * Explore, in a preliminary fashion, possible relationships between pharmacokinetic results and renal and hepatic function and complete blood count. * Explore, in a preliminary fashion, possible genetic polymorphisms that may influence daunorubicin hydrochloride disposition. OUTLINE: This is a multicenter study. Patients undergo blood collection prior to, periodically during, and after treatment with daunorubicin hydrochloride for pharmacokinetic analysis. Patients also undergo body composition testing within 7 days before or after the administration of daunorubicin hydrochloride using dual-energy x-ray absorptiometry. PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study.
Age
0–21
Sex
ALL
Healthy volunteers
Not accepted
